The estimated Net Worth of Wolfgang Dummer is at least $1.56 Million dollars as of 2 February 2023. Dr Dummer owns over 5,389 units of Rigel Pharmaceuticals stock worth over $939,793 and over the last 6 years he sold RIGL stock worth over $8,946. In addition, he makes $614,363 as Exec. VP & Chief Medical Officer at Rigel Pharmaceuticals.
Dr has made over 1 trades of the Rigel Pharmaceuticals stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 5,389 units of RIGL stock worth $8,946 on 2 February 2023.
The largest trade he's ever made was selling 5,389 units of Rigel Pharmaceuticals stock on 2 February 2023 worth over $8,946. On average, Dr trades about 599 units every 0 days since 2018. As of 2 February 2023 he still owns at least 72,459 units of Rigel Pharmaceuticals stock.
You can see the complete history of Dr Dummer stock trades at the bottom of the page.
Dr. Wolfgang Dummer M.D., Ph.D. is the Exec. VP & Chief Medical Officer at Rigel Pharmaceuticals.
As the Exec. VP & Chief Medical Officer of Rigel Pharmaceuticals, the total compensation of Dr D at Rigel Pharmaceuticals is $614,363. There are 3 executives at Rigel Pharmaceuticals getting paid more, with David A. Santos having the highest compensation of $1,034,977.
Dr D is 55, he's been the Exec. VP & Chief Medical Officer of Rigel Pharmaceuticals since . There are 5 older and 1 younger executives at Rigel Pharmaceuticals. The oldest executive at Rigel Pharmaceuticals is Raul R. Rodriguez, 60, who is the Pres, CEO & Director.
Wolfgang's mailing address filed with the SEC is C/O ALPINE IMMUNE SCIENCES, INC., 188 EAST BLAINE STREET, SUITE 200, SEATTLE, WA, 98102.
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke, and Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: